Clinical Trial Update: Atomoxetine for Freezing of Gait in Parkinson's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of atomoxetine for freezing of gait in Parkinson's disease has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Freezing of Gait
• Parkinson Disease

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Parkinson's Disease, Freezing of Gait | Phase 3 | Status: COMPLETED | Results posted: 2018-11-28